CORDIS' SLEEK CATHETER RECEIVES "APPROVABLE LETTER"
MIAMI, May 3 /PRNewswire/ -- Cordis Corporation (NASDAQ-NMS: CORD) said today that the Food and Drug Administration has issued an "approvable letter" on the company's most advanced balloon angioplasty catheter to date: Sleek PTCA Dilatation Catheter. Actual market release must await the review of additional data, information the company said it is in a position to provide by Friday (May 7) of this week. Robert C. Strauss, president and chief executive officer, called the action significant. "Naturally," he said, "we would have liked to been able to launch Sleek in the US immediately, but in today's difficult regulatory environment, Cordis is fortunate indeed. We intend to immediately accelerate production and sales training so that when final approval is received, the company will be positioned to act." Like other angioplasty devices, Sleek over-the-wire catheters help open coronary arteries occluded by the buildup of fatty deposits, or plaque, associated with atherosclerosis. Sleek catheters, however, which can accommodate up to an .014 guidewire, offer high performance with some of the lowest profiles in the industry. In fact, their profiles rival those of even the lowest fixed-wire catheters, a feature that enables doctors to treat particularly tortuous and distal lesions. Cordis said that Sleek catheter sales have been strong for several months in Japan, Canada and, most recently, Europe. The device is expected to be a major contributor to the company's steadily improving angioplasty position in the large US market. Miami-based Cordis Corporation manufactures and markets a variety of medical devices and systems for the angiographic and neuroscience markets. -0- 5/3/93 /CONTACT: Chick McDowell, vice president, corporate relations and assistant secretary of Cordis Corporation, 305-824-2821/ (CORD)
CO: Cordis Corporation ST: Florida IN: MTC SU:
JB-AW -- FL015 -- 3964 05/03/93 16:29 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||May 3, 1993|
|Previous Article:||FISCHER IMAGING ACQUIRES X-RAY SUBSYSTEMS PRODUCT LINES FROM VARIAN ASSOCIATES....AND INVESTS IN TETRAD|
|Next Article:||THREE-WAY PARTNERSHIP FORMS TO BRINGMULTIPLEX THEATERS TO NETHERLANDS|